SS Innovations International, Inc.(SSII)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

SS Innovations International, Inc. (SSII) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SSII at 30.4/100 on a 32-signal composite quality model, placing it at rank #2,488 of 2,962 stocks — the bottom half of the AI-ranked universe. SSII scores in the top quartile across revenue growth (97.4). Areas of concern include earnings quality (6.3) and revenue scale (9.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 9.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), SS Innovations International, Inc. reports quarterly revenue of $13.9M, net income of $-2.7M, an operating margin of -16.3%. Top institutional holders of SSII by reported 13-F value include Hood River Capital Management, Inspire Investing, Handelsbanken Fonder AB, based on the most recent SEC filings. SSII trades on the Nasdaq exchange and files with the SEC under CIK 1676163. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SSII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SS Innovations International, Inc. directly from SEC EDGAR.

AI Quality Score

30.4/100

AI Rank

#2,488

Revenue

$13.9M

Net Income

$-2.7M

Operating Margin

-16.3%

SSII key financials by period

SS Innovations International, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$42.5M$-12.1M-19.3%
FY 202410-K$20.6M$-19.2M-91.9%
FY 202310-K/A$5.9M$-20.9M
FY 202210-K/A$1.4M$-3.2M

Institutions holding SSII

Institutional investors reporting a position in SS Innovations International, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Hood River Capital Management833,333$3.5M2026-06-30
Inspire Investing186,297$773.1K2026-06-30
Handelsbanken Fonder AB120,000$498.0K2026-06-30
Eversept Partners110,157$457.2K2026-06-30
JNBA Financial Advisors102,291$424.5K2026-06-30
UBS Group AG51,208$212.5K2026-06-30
AlphaCentric Advisors50,000$207.5K2026-06-30
GEODE CAPITAL MANAGEMENT41,771$173.3K2026-06-30
Forum Financial Management38,469$159.6K2026-06-30
AlTi Global20,555$85.3K2026-06-30
SSII

SS Innovations International, Inc.

SSII
NasdaqSmall CapHealthcare

13F Pro Quality Score

30.4/100

Rank #2,488 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

97.4/100

Profitability

16.4/100

Balance Sheet

13.4/100

Earnings Quality

6.3/100

Free Cash Flow

11.0/100

Institutional Flow

24.7/100

Revenue Scale

9.3/100

Dilution Risk

9.3/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$13.94M

Net Income

Q2 2026
EDGAR

$-2.66M

EPS (Diluted)

Q2 2026
EDGAR

$-0.01

Operating Margin

Q2 2026
EDGAR

-16.3%

ROIC

Q2 2026
EDGAR

-17.0%

Top Institutional Holders

as of Q2 2026
$6.82M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…